Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Infosys Technologies Limited ( INFY - Analyst Report ) reported third quarter fiscal 2013 earnings per ADS from continuing operations of 76 cents, beating the Zacks Consensus Estimate of 72 cents by 5.6%. However, earnings were down 5.0% year over year and 1.3% sequentially. Profits in the quarter were impacted by delayed decision-making by customers, cancellations of projects, continued margin pressure and Hurricane Sandy (as the company primarily has operations in the East Coast).
Business Details
Total revenue for the quarter was $1.9 billion, up 5.8% year over year. The company saw growth in retail and manufacturing as well as in banking and insurance. The company delivered a decent quarter in terms of client additions. During the reported quarter, Infosys added 14 new clients for Infosys’ products and platforms. Apart from this, Infosys and its subsidiaries added 53 clients during the quarter. Infosys added 8 large outsourcing deals worth $731 million. The company’s cloud-based offerings attained good momentum during the quarter.
Further, Infosys completed the Lodestone Holding AG acquisition related procedures as projected. Based in Lodestone Holding AG, is a leading management consultancy.
Geographical segments
During the reported quarter, revenue in North America grew 1.6% both sequentially and in constant currency. In Europe, revenues grew 16.6% sequentially and 14.4% in constant currency. Revenues in India grew 44.7% sequentially while revenues from the Rest of the world increased 7.4% both sequentially and in constant currency.
Segment Details
Revenues in the Financial Services segment (FSI) climbed 6.4% sequentially and 6.0% in constant currency in the third quarter of 2012. Manufacturing segment (MFG) revenues increased 4.6% sequentially and 4.0% in constant currency. Revenues from the Retail and Life Sciences division (RCL) went up 6.6% sequentially and 6.2% in constant currency, while revenues in the Energy, Utilities, Communications & Services (ECS) improved 7.8% sequentially and 7.1% in constant currency.
Income
The company recorded an operating profit of $491 million compared to $560 million in the prior-year period. Net profit after tax was $434 million for the quarter, down 5.2% year over year.
Operating margin during the reported quarter contracted 531 basis points (bps) to 25.7% versus 31.0% in the prior year period. Margins of the company have been under pressure for more than 4-5 quarters now.
Balance Sheet
Infosys maintains a strong liquidity position and had cash & cash equivalents (including investments in available-for-sale financial assets, certificates of deposits and government bonds) of 2.7 billion as of December 31, 2012 compared to $4.0 billion as of March 31, 2012.
Outlook
Concurrent with the earnings release, management also provided a brief outlook for 2013. Earnings per ADS are expected to be $2.97 while revenues for 2013 are expected to be at least $7.5 billion.
Infosys currently has a short term Zacks Rank #3 (Hold) rating on the stock. Two of the company’s peers Cognizant Technology Solutions. ( CTSH - Analyst Report ) and Accenture PLC ( ACN - Snapshot Report ) are short-term Zacks Rank #3 (Hold) stocks.
Read the full reports :
Analyst Report on INFY
Snapshot Report on ACN
Analyst Report on CTSH